US Army Awards ADA $70K to Develop 'Lab-on-a-Chip' Technology
News Jul 14, 2011
ADA Technologies has announced it has received a $70,000 contract from the US Army to develop a "lab-on-a-chip" technology to identify biological hazards in complex matrices.
The contract is for Phase 1 research into the development of the sampling platform, which will be used to identify hazards such as toxins, viruses, vegetative bacteria, and spores in matrices including blood, soil, food, and water.
In a statement, ADA Chief Technology Officer Steven Arzberger said that currently, highly trained laboratory personnel need to perform multiple separate steps on large sample sizes to obtain enough material for biological hazard analysis and identification.
"ADA's lab-on-a-chip not only saves time, but improves efficiency because it can be carried out by virtually anyone, regardless of training level," he said.
ADA is a technology development and commercialization firm based in Littleton, Colo. It received a $1.15 million grant from the National Institutes of Health two years ago to develop an analytical tool for analyzing carbohydrate-protein interactions in drug discovery and diagnostics research.
In late 2008, the National Cancer Institute gave ADA a $149,121 grant to develop a nanotechnology-based imaging and sensing platform for discovering cancer biomarkers.
Diagnosing Immunity to Ebola With Paper Tests & SmartphonesNews
A promising new approach to detect immunity to Ebola virus infection has been developed by researchers from i-sense in a collaboration between UCL and Imperial College London.READ MORE
New Technique Eases Production, Customization of Soft RoboticsNews
By helping rubber and plastic stick together under pressure, University of Nebraska-Lincoln chemists have simplified the production of small fluid-carrying channels that can drive movement in soft robotics and enable chemical analyses on microscopic scales.READ MORE
New Preservation Method Maintains Viable CTCs for up to 72 HoursNews
A new blood stabilization method significantly prolongs the lifespan of blood samples for microfluidic sorting and transcriptome profiling of rare circulating tumor cells.READ MORE